Call for Tenders: Studies on eHealth, Interoperability of Health Data and Artificial Intelligence for Health and Care in the EU

European CommissionThe European Commission is launching a tender for two studies to survey and analyse progress on the digital transformation of the health and care in the EU, in particular with regard to citizens' access to their electronic health records (EHR) in the EU Member States and the development, adoption and use of artificial intelligence (AI) technologies in the health and care sector in the EU.

The call for tender includes two specific studies (i.e. lots), and tenderers are free to apply for one or both lots:

Lot I: Interoperability of Electronic Health Records in the EU

This study will survey and analyse the current situation in the EU Member States with regard to the development of interoperable electronic health records systems and enabling technological solutions such as electronic identification, distributed ledger and cybersecurity.

Lot II: Artificial Intelligence for Health and Care in the EU

This study will survey and analyse the current situation in the EU Member States with regard to the development, adoption and use of AI technologies and applications in the health and care sector.

The maximum amount allocated to the studies is EUR 300 000 for Lot I and EUR 200 000 for Lot II.

The closing date of the call is 23 September 2019 at 15:00.

Study reference: SMART 2019/0056

The detailed tender specifications and more information about the procedure and eligibility conditions are available on TED.

For questions and clarifications, please use the online interface.

Most Popular Now

Researchers Capture First Images of Oxyg…

Oxygen in cancer tumors is known to be a major factor that helps radiation therapy be successful. Hypoxia, or starvation of oxygen, in solid tumors is also thought to be...

VTT Makes New Investments in Digital Hea…

VTT is launching new research activities in the area of digital health as part of the growing wellbeing and health technology ecosystem in Kuopio. The new initiative aims to create...

A New Method of Artificial Intelligence …

Despite the immense progress in the field of AI in recent years, we are still very far from human intelligence. Indeed, if current AI techniques allow to train computer agents...

FDA Informs Health Care Providers, Facil…

Today, the U.S. Food and Drug Administration is issuing a safety communication informing health care providers, facilities and patients about cybersecurity vulnerabilities identified for certain GE Healthcare Clinical Information Central...

eHealthWeek 2020 Croatia - Trusted Infor…

15 - 17 April 2020, Rovinj, Croatia. In its capacity of hosting the upcoming Presidency of the Council of the European Union, the Croatian Ministry of Health is in preparations to...

Siemens Healthineers Presents Solutions …

CT scanners with intelligent user guidance, AI-based software assistants for MRI and a lab system that revolutionizes workflows: Siemens Healthineers is showcasing its products and solutions according to the motto...

NHS IT Chiefs Set the Stage for a Year o…

3 - 4 March 2019, London, United Kingdom. NHS technology leaders are to kick off the second-ever Digital Health Rewired Conference and Exhibition on 3 - 4 March at the Olympia...

PatchAi Startup has Arrived in the Marke…

PatchAi - a startup that offers, thanks to Artificial Intelligence and Machine Learning, an empathic virtual assistant to patients participating in clinical trials - announced that it has closed two...

Digital Health App Medicus AI Earns CE C…

Medicus AI, the Vienna-based health tech company, has received a ​Class I Medical Device CE Mark for its mobile application. The CE certification mark confirms that Medicus AI conforms to...

FDA Authorizes Marketing of First Cardia…

Today, the U.S. Food and Drug Administration authorized marketing of software to assist medical professionals in the acquisition of cardiac ultrasound, or echocardiography, images. The software, called Caption Guidance, is...

Human Body-on-Chip Platform Enables In V…

Drug development is an extremely arduous and costly process, and failure rates in clinical trials that test new drugs for their safety and efficacy in humans remain very high. According...

AI in Drug Discovery Conference 2020

16 - 17 March 2020, London, UK. SMi group presents the launch of the inaugural AI in Drug Discovery conference taking place in London. AI-empowered machine learning technologies hold the potential...